PureTech News

Press Releases
ALL >
Press Release - 2026-04-02
Celea Therapeutics – Deupirfenidone (LYT-100)
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
Continue
Press Release - 2026-04-02
Seaport
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
Continue
Press Release - 2026-03-25
Seaport
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
Continue
Publications
ALL >
Publications 2026-04-02
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Full Article
Publications 2026-03-25
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans
Full Article
Publications 2025-05-08
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
Full Article

@PureTechH